Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jinan Kelongboao Bio-Tech (JKB) is a biotechnology company based in Jinan, China, specializing in the development of anti-viral solutions for the veterinary and agricultural sectors. Founded in 2002 and affiliated with the Chinese Academy of Medical Sciences, the company is best known for its proprietary AF-01 aerosol technology, a broad-spectrum anti-viral agent effective against various RNA viruses. This technology is primarily used to prevent and treat diseases such as avian influenza and foot-and-mouth disease in livestock and poultry. JKB entered a significant technology transfer agreement with Kiwa Bio-Tech Products Group Corp, enabling the large-scale manufacturing and commercialization of its aerosol products in both domestic and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jinan Kelongboao Bio-Tech.